Search
for
Sort by
Research 91–120 of 1000+
- A Characterization of Disparities in Published Alopecia Quality of Life Studies
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Baseline Neutrophil-to-Lymphocyte Ratio Stratifies Early Trichoscopic Response to Platelet-Rich Plasma–Based Regimens in Non-Scarring Alopecia: A Real-World Cohort with Internal Validation Using an Interpretable Neural Network
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic Review and Meta-analysis
- Signal Detection for Adverse Events of Finasteride Using Korea Adverse Event Reporting System (KAERS) Database
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series
- Medical consequences of long-term anabolic-androgenic Steroids (AASs) abuses in athletes
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Keratin disorders: from gene to therapy
- Hunting the genes in male‐pattern alopecia: how important are they, how close are we and what will they tell us?
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Debatable Topics in PCOS Patients
- Androgen excess: a hallmark of polycystic ovary syndrome
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- The effect of menopause on the skin and other connective tissues
- Women’s Health Considerations for Lipid Management
- Sex hormones and related compounds, including hormonal contraceptives